Versatile Supramolecular Complex for Targeted Antimicrobial Photodynamic Inactivation.

Area of Science:

• Biochemistry
• Photochemistry
• Microbiology

Background:

• Antimicrobial photodynamic inactivation (aPDI) offers a promising alternative to antibiotics.
• Targeted delivery of photosensitizers can enhance aPDI efficacy and specificity.

Purpose of the Study:

• To develop a supramolecular photosensitizing agent with specific targeting capabilities for antimicrobial applications.
• To evaluate the efficacy of the developed agent against Staphylococcus aureus.

Main Methods:

• Synthesis of a streptavidin-eosin complex.
• Conjugation of biotinylated immunoglobulin G (IgG) to the streptavidin-eosin complex.
• Characterization of binding to Staphylococcus aureus using fluorescence correlation spectroscopy and microscopy.
• Assessment of antimicrobial photodynamic inactivation efficacy.

Main Results:

• Successful development of a targeted supramolecular complex (IgG-streptavidin-eosin).
• Demonstrated specific binding of the complex to Staphylococcus aureus.
• Achieved efficient photoinactivation of Staphylococcus aureus suspensions at concentrations >0.5 μM under green light irradiation.

Conclusions:

• The developed IgG-streptavidin-eosin complex is an effective photosensitizer for targeted antimicrobial photodynamic inactivation of Staphylococcus aureus.
• This strategy provides a flexible platform for developing novel antimicrobial agents targeting various microbial species.
• Further research may explore applications against other pathogens and optimize delivery systems.